Breaking News Instant updates and real-time market news.

FOMX

Foamix

$3.15

-0.09 (-2.78%)

14:46
10/18/19
10/18
14:46
10/18/19
14:46

Foamix trading halted, news pending

  • 18

    Oct

  • 20

    Oct

FOMX Foamix
$3.15

-0.09 (-2.78%)

12/12/18
12/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Foamix (FOMX) initiated with a Buy at BofA/Merrill. 2. Jazz Pharmaceuticals (JAZZ) initiated with an Outperform at Oppenheimer while GW Pharmaceuticals (GWPH) was initiated with a Perform. 3. Six Flags (SIX) initiated with a Buy at Berenberg. 4. iQIYI (IQ) initiated with a Hold at HSBC. 5. Intercept (ICPT), Viking Therapeutics (VKTX), and Galmed (GLMD) were initiated with a Buy at B. Riley FBR, while Madrigal Pharmaceuticals (MDGL) initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/11/19
LEHM
06/11/19
INITIATION
Target $10
LEHM
Overweight
Foamix initiated with an Overweight at Barclays
Barclays analyst Balaji Prasad started Foamix Pharmaceuticals with an Overweight rating and $10 price target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.
10/08/19
CANT
10/08/19
NO CHANGE
Target $15
CANT
Overweight
Cantor reiterates Overweight on Foamix ahead of FMX101 PDUFA
Cantor Fitzgerald analyst Louise Chen says her 25 physician survey supports her positive view on the market opportunity for Foamix's FMX10. If approved, FMX101 has the potential to address a significant unmet need in the treatment of moderate-to-severe acne, which remains a difficult condition, Chen tells investors in a research note. She reiterates an Overweight rating on Foamix shares with a $15 price target ahead of the upcoming FDA action date for FMX101 on October 20. The analyst thinks the Street is underestimating the uptake of acne drugs.
10/16/19
LEHM
10/16/19
NO CHANGE
Target $10
LEHM
Overweight
Barclays likes Foamix setup into October 20 FDA action date
Barclays analyst Balaji Prasad highlights Foamix Pharmaceuticals' key upcoming FDA action date of October 20 for FMX-101 in acne. The analyst says ~75% of his $10 price target is derived from FMX-101, and that approval could add another $2, or 320% potential upside from current share levels. The analyst sees a 90% probability of success and forecasts 2025 risk adjusted sales of $202M. Prasad continues to like Foamix's risk/reward setup going into the October 20 PDUFA and he reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

NXPI

NXP Semiconductors

$114.81

-1.13 (-0.97%)

, QCOM

Qualcomm

$87.43

-3.04 (-3.36%)

13:30
11/19/19
11/19
13:30
11/19/19
13:30
Hot Stocks
NXP Semiconductors down 1% as Qualcomm conducts analyst day meeting »

Qualcomm (QCOM) has been…

NXPI

NXP Semiconductors

$114.81

-1.13 (-0.97%)

QCOM

Qualcomm

$87.43

-3.04 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

13:30
11/19/19
11/19
13:30
11/19/19
13:30
General news
Treasury Action: yields have continued to richen in cautious trading »

Treasury Action: yields…

BA

Boeing

$367.75

-1.75 (-0.47%)

13:26
11/19/19
11/19
13:26
11/19/19
13:26
Periodicals
Boeing says following NTSB recommendation, redesigning engine cover on 737 NG »

In an emailed statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$8.35

0.77 (10.16%)

13:25
11/19/19
11/19
13:25
11/19/19
13:25
Options
ArQule call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/19/19
11/19
13:17
11/19/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/19/19
11/19
13:16
11/19/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MUR

Murphy Oil

$23.43

-0.29 (-1.22%)

13:15
11/19/19
11/19
13:15
11/19/19
13:15
Options
Murphy Oil put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$182.47

4.45 (2.50%)

13:14
11/19/19
11/19
13:14
11/19/19
13:14
Hot Stocks
Abiomed says AHA analysis of Impella 'flawed' »

The Abiomed medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$110.46

-0.13 (-0.12%)

, LOW

Lowe's

$113.37

-1.66 (-1.44%)

13:14
11/19/19
11/19
13:14
11/19/19
13:14
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

TGT

Target

$110.46

-0.13 (-0.12%)

LOW

Lowe's

$113.37

-1.66 (-1.44%)

NTES

NetEase

$287.03

-3.07 (-1.06%)

CPRT

Copart

$86.50

0.49 (0.57%)

LB

L Brands

$17.21

-0.65 (-3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 05

    Dec

  • 06

    Dec

URBN

Urban Outfitters

$29.13

-1.03 (-3.42%)

, ALC

Alcon

$58.96

0.07 (0.12%)

13:14
11/19/19
11/19
13:14
11/19/19
13:14
Earnings
Notable companies reporting after market close »

Notable companies…

URBN

Urban Outfitters

$29.13

-1.03 (-3.42%)

ALC

Alcon

$58.96

0.07 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 05

    Dec

GOOG

Alphabet

$1,318.29

-0.16 (-0.01%)

, GOOGL

Alphabet Class A

$1,316.50

-3.67 (-0.28%)

13:09
11/19/19
11/19
13:09
11/19/19
13:09
Hot Stocks
Google introduces Your News Update »

Google said in a blog…

GOOG

Alphabet

$1,318.29

-0.16 (-0.01%)

GOOGL

Alphabet Class A

$1,316.50

-3.67 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANN

General Cannabis

$0.00

(0.00%)

13:06
11/19/19
11/19
13:06
11/19/19
13:06
Hot Stocks
General Cannabis to sell Greenhouse Office building for approx. $1.7M »

General Cannabis Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$31.90

0.38 (1.21%)

13:05
11/19/19
11/19
13:05
11/19/19
13:05
Options
MGM Resorts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMI

Cummins

$183.46

-0.13 (-0.07%)

, TSLA

Tesla

$358.76

8.77 (2.51%)

13:01
11/19/19
11/19
13:01
11/19/19
13:01
Hot Stocks
Electric truck firm Nikola to unveil 'game-changing' battery cell technology »

Nikola Motor, which…

CMI

Cummins

$183.46

-0.13 (-0.07%)

TSLA

Tesla

$358.76

8.77 (2.51%)

NAV

Navistar

$32.22

-0.3 (-0.92%)

GM

General Motors

$36.60

-0.02 (-0.05%)

PCAR

Paccar

$79.50

-0.48 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRSP

Crispr Therapeutics

$67.82

9.3 (15.89%)

12:57
11/19/19
11/19
12:57
11/19/19
12:57
Recommendations
Crispr Therapeutics analyst commentary  »

Crispr Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

EPD

Enterprise Products

$25.24

-0.54 (-2.09%)

12:55
11/19/19
11/19
12:55
11/19/19
12:55
Options
Enterprise Products put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$47.25

-1.09 (-2.25%)

12:47
11/19/19
11/19
12:47
11/19/19
12:47
Recommendations
Altria Group analyst commentary  »

Altria slide on Juul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

MRK

Merck

$84.13

0.01 (0.01%)

12:44
11/19/19
11/19
12:44
11/19/19
12:44
Hot Stocks
Merck boosts quarterly dividend to 61c from 55c »

Merck announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 10

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

FNV

Franco-Nevada

$99.27

0.25 (0.25%)

12:40
11/19/19
11/19
12:40
11/19/19
12:40
Options
Put spread in Franco Nevada rolls position to higher delta »

Put spread in Franco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBCP

Independent Bank

$22.47

0.09 (0.40%)

12:39
11/19/19
11/19
12:39
11/19/19
12:39
Hot Stocks
Independent Bank CFO Robert Shuster sells over $185K in company shares »

Independent Bank CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

NFLX

Netflix

$302.89

0.22 (0.07%)

, DIS

Disney

$148.62

0.97 (0.66%)

12:37
11/19/19
11/19
12:37
11/19/19
12:37
Periodicals
Survey finds Netflix cancelers blame price hikes, content for leaving, blog says »

Helen Back wrote in the…

NFLX

Netflix

$302.89

0.22 (0.07%)

DIS

Disney

$148.62

0.97 (0.66%)

AAPL

Apple

$266.45

-0.58 (-0.22%)

CMCSA

Comcast

$44.69

0.08 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

AUPH

Aurinia Pharmaceuticals

$5.92

0.17 (2.96%)

12:25
11/19/19
11/19
12:25
11/19/19
12:25
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,318.96

0.51 (0.04%)

, GOOGL

Alphabet Class A

$1,318.08

-2.09 (-0.16%)

12:19
11/19/19
11/19
12:19
11/19/19
12:19
Periodicals
'Big Tech' firms 'defend' themselves in responses to regulators, Reuters says »

Alphabet's Google…

GOOG

Alphabet

$1,318.96

0.51 (0.04%)

GOOGL

Alphabet Class A

$1,318.08

-2.09 (-0.16%)

FB

Facebook

$199.25

1.8 (0.91%)

AMZN

Amazon.com

$1,753.39

0.69 (0.04%)

AAPL

Apple

$266.15

-0.88 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 26

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/19/19
11/19
12:17
11/19/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/19/19
11/19
12:16
11/19/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.